1149878

Mehrnaz Hojjati MD — FEI 3017144188

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 26, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Loma Linda, CA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance